Categories

September 29, 2020

My News on Point

Daily News Update From Top News Blog Around The World | Your News on The Go

WHO names Nigerian centre as African reference laboratory for genome research

3 min read

The African Centre of Excellence for the Genomics of Infectious Disease (ACEGID), Redeemer’s University, Ede, Osun State, has been named one of the regional repository and bioinformatics centres by the WHO and Africa CDC to provide sequencing, data analysis and other technical support services to the countries where they are located as well as to neighbouring countries and countries in their sub-regions.

This development was announced on Thursday, September 10, by the WHO and the Africa CDC through a press release announcing the launch of a network of laboratories to reinforce genome sequencing of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, in Africa.

“As we continue to tackle the COVID-19 pandemic in Africa, being able to not only track its evolution but also assess the possible mutation of the virus is crucial to mounting an effective response,” said Matshidiso Moeti, WHO Regional Director for Africa. “Through this new laboratory network dedicated to genome sequencing, we can better develop vaccines and treatment which are tailored to Africans and eventually bring COVID-19 under control.”

ACEGID, South African National Bioinformatics Institute (SANBI), and Kwazulu-Natal Research Innovation and Sequencing Platform (KRISP) South Africa are the three regional repository centres charged with the responsibility of establishing a continental virus sequence repository, prepare and validate test kits, support laboratory accreditation and quality assurance processes among others.

Commenting on its new role, Christian Happi, the Director of ACEGID, told PREMIUM TIMES, that being named one of the reference laboratories, “is a recognition of what ACEGID has done for the continent and for the world, it is a great feat. It means that ACEGID has become a globally recognised and competitive entity when it comes to infectious disease research and genomics.”

“Being a reference laboratory on the continent, we have a mandate to support the 54 African countries in their quest for infectious disease research capacity development, training.”

According to Mr Happi, this means more work for the laboratory. “The reality is that it is more work for us because now we have an African and a global mandate: it means we have to operate at a different level, set standards, be a role model for every other laboratory on the continent” adding that ACEGID has to leave up to this by playing its role as a leader on the continent and one of the leaders globally.

“This definitely comes with a lot of pressure and responsibility,” he remarked.

Responding to the question on the capability of ACEGID to perform this function, Mr Happi said the Africa CDC and WHO conducted an extensive assessment of facilities and capacities across the continent. This assessment brought about the naming of the various laboratories that make up the network of laboratories.

ACEGID has been at the fore in the fight against infectious diseases in Nigeria: in 2014, it confirmed the first case of Ebola in Nigeria and developed a rapid diagnostics test approved by the US FDA and the WHO; after the first case of COVID-19 was confirmed in Lagos, the sample was made available to the laboratory where it was sequenced within 48 hours.

“In 2019, Africa CDC launched the Institute for Pathogen Genomics to support the integration of pathogen genomics and bioinformatics into public health surveillance, outbreak detection and investigations, and improve disease control and prevention in Africa. The establishment of the COVID-19 sequencing network will help improve surveillance in the continent and help countries to effectively manage and control the pandemic. As the COVID-19 pandemic curve flattens in Africa, we must be prepared for a possible resurgence as already observed in some countries. With genomic sequencing we can have a better understanding of the pandemic through more precise identification of transmission clusters,” said John Nkengasong, Director of Africa CDC.

While ACEGID, SANBI and KRISP serve at the continental level performing oversight functions, Institut Pasteur, Dakar, Senegal; Noguchi Memorial Institute for Medical Research (NMIMR), Ghana; The Institut National de la Recherche Biomédicale (INRB), DRC; Centre International de Recherches Médicales de Franceville (CIRMF), Gabon; Uganda Virus Research Institute (UVRI), Uganda; National Institute for Communicable Diseases (NICD), South Africa; Kenya Medical Research Institute (KEMRI), Kenya; National Centre for Disease Control (NCDC), Nigeria serve at national and regional levels.



Advertisement

PT Mag Campaign AD




Source link

Facebook Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Follow Us
  • Contribute to MyNewsonPoint - Register to become an author to contribute with your knowledge.
  • Send breaking news, releases, photos or videos of happenings around the world Us via
Live Updates COVID-19 CASES
  • World 33,620,793
    World
    Confirmed: 33,620,793
    Active: 7,686,078
    Recovered: 24,926,999
    Death: 1,007,716
  • USA 7,365,427
    USA
    Confirmed: 7,365,427
    Active: 2,544,223
    Recovered: 4,611,282
    Death: 209,922
  • UK 439,013
    UK
    Confirmed: 439,013
    Active: 397,012
    Recovered: ?
    Death: 42,001
  • Italy 311,364
    Italy
    Confirmed: 311,364
    Active: 50,323
    Recovered: 225,190
    Death: 35,851
  • Nigeria 58,460
    Nigeria
    Confirmed: 58,460
    Active: 7,454
    Recovered: 49,895
    Death: 1,111
  • Ghana 46,482
    Ghana
    Confirmed: 46,482
    Active: 530
    Recovered: 45,651
    Death: 301